![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
33
PharmaCompass offers a list of Desonide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Desonide manufacturer or Desonide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Desonide manufacturer or Desonide supplier.
PharmaCompass also assists you with knowing the Desonide API Price utilized in the formulation of products. Desonide API Price is not always fixed or binding as the Desonide Price is obtained through a variety of data sources. The Desonide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Locapred manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Locapred, including repackagers and relabelers. The FDA regulates Locapred manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Locapred API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Locapred manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Locapred supplier is an individual or a company that provides Locapred active pharmaceutical ingredient (API) or Locapred finished formulations upon request. The Locapred suppliers may include Locapred API manufacturers, exporters, distributors and traders.
click here to find a list of Locapred suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Locapred DMF (Drug Master File) is a document detailing the whole manufacturing process of Locapred active pharmaceutical ingredient (API) in detail. Different forms of Locapred DMFs exist exist since differing nations have different regulations, such as Locapred USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Locapred DMF submitted to regulatory agencies in the US is known as a USDMF. Locapred USDMF includes data on Locapred's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Locapred USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Locapred suppliers with USDMF on PharmaCompass.
A Locapred written confirmation (Locapred WC) is an official document issued by a regulatory agency to a Locapred manufacturer, verifying that the manufacturing facility of a Locapred active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Locapred APIs or Locapred finished pharmaceutical products to another nation, regulatory agencies frequently require a Locapred WC (written confirmation) as part of the regulatory process.
click here to find a list of Locapred suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Locapred as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Locapred API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Locapred as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Locapred and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Locapred NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Locapred suppliers with NDC on PharmaCompass.
Locapred Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Locapred GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Locapred GMP manufacturer or Locapred GMP API supplier for your needs.
A Locapred CoA (Certificate of Analysis) is a formal document that attests to Locapred's compliance with Locapred specifications and serves as a tool for batch-level quality control.
Locapred CoA mostly includes findings from lab analyses of a specific batch. For each Locapred CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Locapred may be tested according to a variety of international standards, such as European Pharmacopoeia (Locapred EP), Locapred JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Locapred USP).